Post Marketing Surveillance of PIRESPA® TAB 200mg (Pirfenidone) for Evaluating the Safety and Efficacy

A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

NCT05176951 ·Status: COMPLETED ·Phase: PHASE2

Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD

NCT05867914 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT07179380 ·Status: RECRUITING ·Phase: PHASE3

Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung Disease

NCT05572996 ·Status: AVAILABLE

Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006)

NCT04370873 ·Status: COMPLETED ·Phase: PHASE1

Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis

NCT00439543 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE

NCT02633293 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT07234032 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

NCT03820726 ·Status: COMPLETED ·Phase: PHASE3

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

NCT00109681 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety of Pirfenidone in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

NCT02932566 ·Status: COMPLETED ·Phase: PHASE2

Simvastatin as a Treatment for Pulmonary Hypertension

NCT00180713 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

NCT02603068 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis

NCT00071461 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)

NCT00882947 ·Status: COMPLETED

Safety and Efficacy of Inhaled Treprostinil in Patients With PAH

NCT01557647 ·Status: WITHDRAWN ·Phase: PHASE3

Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT07181382 ·Status: SUSPENDED ·Phase: PHASE3

Safety of Nintedanib in Real World in China

NCT05676112 ·Status: WITHDRAWN

Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension

NCT00185315 ·Status: COMPLETED ·Phase: PHASE3

Stress Ventricular Function in Evaluating Patients With Pulmonary Hypertension

NCT02647034 ·Status: UNKNOWN

Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease

NCT05844462 ·Status: RECRUITING ·Phase: PHASE3

Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension

NCT00709098 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

NCT05747508 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients

NCT00455767 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)

NCT01553721 ·Status: COMPLETED ·Phase: PHASE2